Anidulafungin dosing during CRRT: do not underestimate adsorption!
作者信息
Honore Patrick M, Jacobs Rita, De Waele Elisabeth, Spapen Herbert D
出版信息
Crit Care. 2014 Oct 30;18(5):618. doi: 10.1186/s13054-014-0618-6.
Abstract
摘要
相似文献
1
Anidulafungin dosing during CRRT: do not underestimate adsorption!连续性肾脏替代治疗（CRRT）期间阿尼芬净的给药：切勿低估吸附作用！
Crit Care. 2014 Oct 30;18(5):618. doi: 10.1186/s13054-014-0618-6.
2
Pharmacokinetics of anidulafungin during albumin dialysis.阿尼芬净在白蛋白透析过程中的药代动力学。
Crit Care. 2014 Mar 31;18(2):422. doi: 10.1186/cc13805.
3
Treatment with echinocandins during continuous renal replacement therapy.持续肾脏替代治疗期间使用棘白菌素类药物治疗。
Crit Care. 2014 Mar 28;18(2):218. doi: 10.1186/cc13803.
4
Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration.连续性静脉-静脉血液透析滤过治疗危重症患者时的安尼白介素剂量。
J Antimicrob Chemother. 2014 Jun;69(6):1620-3. doi: 10.1093/jac/dkt542. Epub 2014 Jan 26.
5
Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries.米卡芬净以100毫克/天的标准剂量给药，在患有严重烧伤的重症患者中可实现足够的血浆药物暴露。
Intensive Care Med. 2015 Feb;41(2):371-2. doi: 10.1007/s00134-014-3586-z. Epub 2014 Dec 3.
6
7
[Echinocandins in a critically ill patient during continuous venovenous renal replacement].
Rev Iberoam Micol. 2012 Apr-Jun;29(2):85-9. doi: 10.1016/j.riam.2012.03.005.
8
[Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].[重症患者念珠菌血症和侵袭性念珠菌病的治疗方法：棘白菌素类药物的作用]
Rev Esp Quimioter. 2017 Oct;30(5):355-367. Epub 2017 Sep 25.
9
[Echinocandins: searching for differences. The example of their use in patients requiring continuous renal replacement therapy].
Rev Esp Quimioter. 2012 Dec;25(4):240-4.
10
Pharmacokinetics and tissue distribution of anidulafungin in rats.阿尼芬净在大鼠体内的药代动力学及组织分布
Antimicrob Agents Chemother. 2008 Jul;52(7):2673-6. doi: 10.1128/AAC.01596-07. Epub 2008 Apr 28.
引用本文的文献
1
Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.艾沙康唑在新冠病毒相关肺曲霉病重症监护患者中的群体药代动力学及高超说明书剂量的蒙特卡洛模拟
J Fungi (Basel). 2023 Feb 6;9(2):211. doi: 10.3390/jof9020211.
2
Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.持续低效透析治疗对危重症患者伊曲康唑血药浓度的影响。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01162-19. Print 2019 Nov.
本文引用的文献
1
Treatment with echinocandins during continuous renal replacement therapy.持续肾脏替代治疗期间使用棘白菌素类药物治疗。
Crit Care. 2014 Mar 28;18(2):218. doi: 10.1186/cc13803.
2
Pharmacokinetics of anidulafungin during albumin dialysis.阿尼芬净在白蛋白透析过程中的药代动力学。
Crit Care. 2014 Mar 31;18(2):422. doi: 10.1186/cc13805.
3
Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review.新型 CRRT 膜在脓毒症和 SIRS 中的应用——床边重症监护医师实用方法综述：系统的结构化综述。
ASAIO J. 2013 Mar-Apr;59(2):99-106. doi: 10.1097/MAT.0b013e3182816a75.
4
Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.连续静脉-静脉血液滤过期间阿尼芬净的多次剂量药代动力学。
J Antimicrob Chemother. 2011 Apr;66(4):880-4. doi: 10.1093/jac/dkq545. Epub 2011 Jan 22.
Zotero 插件